Airbnb (ABNB) Stock Plunges 7% as Meta’s Muse AI Disrupts Travel Booking
Airbnb (ABNB) shares tumbled 7% after Meta's Muse AI demonstrated direct booking capabilities, threatening the travel platform's c...
Artelo Biosciences (ARTL) Stock Rockets 206% After Obesity Treatment Patent Fili...
Artelo Biosciences (ARTL) stock skyrocketed 206% after filing a patent for obesity drug ART27.13, supported by promising weight-lo...
Fastly (FSLY) Stock Soars 14% on Ambitious 2029 Revenue Forecast and AI Push
Fastly (FSLY) stock surged 14% after the company announced 2029 revenue goals up to $1.3 billion and launched AI security tools at...
aTyr Pharma (ATYR) Gains 5% After Securing FDA Protocol Approval for Phase 3 Sar...
aTyr Pharma (ATYR) stock surged 5% after securing FDA agreement on Phase 3 trial protocol for efzofitimod in pulmonary sarcoidosis...
GlucoTrack (GCTK) Stock Soars 118% on Lōkahi’s Debut Partnership Agreement
GlucoTrack (GCTK) stock rocketed 118% premarket as Lōkahi Therapeutics secured its first partnership deal with glioblastoma resear...
IonQ (IONQ) Stock Surges 4% After Securing Nvidia Quantum Partnership
IonQ (IONQ) stock gained 4% after Nvidia chose its Superion 256 quantum computer for a new quantum research center, outperforming...
Everpure (P) Stock Surges 7% Following Ambitious AI Revenue Forecast
Everpure (P) stock surged 7% premarket after projecting fiscal 2028 revenue of $7.3B, with analysts raising targets following the...
Grail (GRAL) Stock Surges 36% Following Positive FDA Advisory Panel Vote on Gall...
Grail (GRAL) stock surged 36% after FDA panel voted 7-2 in favor of Galleri cancer test. What's next for approval and revenue grow...
MGM Resorts (MGM) Stock Tumbles 8% as Barry Diller Abandons Takeover Proposal
MGM Resorts (MGM) stock plunged 8% after Barry Diller's People Inc. withdrew its $48.30 buyout proposal while maintaining a 27% ow...
Moderna (MRNA) Stock Reaches New 52-Week Peak Amid Cancer Treatment Breakthrough...
Moderna (MRNA) reached a 52-week high as CEO Bancel emphasized the company's mRNA platform capabilities beyond COVID vaccines, spo...